Technical

Technical — The Price Picture

The Numbers tab told you earnings are still growing. The tape is telling you something different. COO trades at $64.96 — within 5% of its 52-week low, -12.8% under a flat 200-day moving average, with RSI in the mid-20s and a fresh bearish MACD crossover. Relative to the S&P 500, the stock has given back more than 70 points of rebased performance in 36 months. This page commits to a stance at the bottom: near-term bearish, with two specific levels that would flip the view.

1. Price snapshot

2. The critical chart: 10 years of price vs 50/200 SMA

Price is below the 200-day by 12.8%. The 200-day is flat-to-falling, the 50-day just rolled over beneath it, and price sits $10 below both. The golden cross of December 19, 2025 was false-started — the stock rallied into year-end, then broke down through both MAs in March 2026.

This is a downtrend regime from the August 2024 peak near $112. The tape is three steps lower — prior peaks in early 2024, September 2024 and February 2026 each failed at successively lower highs.

3. Relative strength vs SPY and Healthcare sector (XLV)

The gap is widening, not narrowing. SPY is up ~71% from the rebase point while XLV has added only ~9% — and COO has fallen 33% over the same window. That is a gross underperformance of roughly 100 points versus the index and 40 points versus the sector. Nothing in the recent tape suggests this divergence is closing; both the absolute chart and the relative chart are making fresh lows.

4. Momentum panel — RSI(14) and MACD histogram, 18 months

The most recent daily RSI reading (April 23) sits at 26 — deeply oversold, the third such print in the last 12 months. Each prior oversold reading (March 2025, June 2025, March 2026) was followed by a 1–3 week bounce, not a sustained reversal. The MACD histogram bounced back above zero in early April but is already flattening near the waterline — momentum has had multiple chances to break higher and each time failed. Near-term bias is for another mean-reversion bounce, but nothing in this panel argues for a durable trend change.

5. Volume and conviction

Conviction on down-days far outweighs conviction on up-days. Of the three biggest recent volume events, two were down-closes in excess of 12%, both tied to disappointing prints or guidance. The single big up-day on December 5 did not follow through — the stock rolled over into the March 2026 breakdown. Declining 50-day average volume since November (3.0M to 1.9M) means the recent slide lacks "capitulation" character — sellers are persistent but not panicked, which typically produces a grinding downtrend rather than a washout low.

6. Volatility regime — 30-day realized, 5 years

Despite the trend damage in the underlying price, options-implied risk is unremarkable. Volatility spiked into the 40–50% range through 2025 around earnings prints but has compressed back to a normal 25% going into the April close. The tape is not pricing a further shock — it is pricing a quiet drift. That removes one catalyst (vol crush) but also means the market has already digested the bad news; any surprise upside in guidance would not be absorbed by elevated hedging demand.

7. Technical scorecard + 3–6 month stance

Net tally: four negative, two neutral, zero positive.

Stance: bearish on a 3–6 month horizon

The weight of the evidence points the same way the Numbers tab's margin-pressure narrative does — the price action is confirming, not contradicting, the fundamental softness flagged in Q2 and Q3 FY25 prints. An oversold RSI could deliver a quick 5–8% relief rally into $70–72 (the declining 50-day), but every bounce since August 2024 has failed at lower highs. Until that sequence breaks, the default trade is down-and-sideways.

• Confirmation of bullish case — reclaim and hold above $82. That level is simultaneously the declining 100-day SMA, the December 2025 / February 2026 swing high, and the pre-breakdown range. Closing above it on above-average volume would confirm a higher-low structure and force a view change.
• Confirmation of bearish case — decisive break under $61.80 (the 52-week low). The 2020 pandemic low near $65 is already compromised; a weekly close below $61.80 on elevated volume would open a measured move toward the 2022 cycle low near $58 and turn "cheap" into "cheaper."

For long-horizon investors: the fundamentals (see Numbers) argue the franchise is intact. The tape argues you do not need to own it yet. Wait for a close above $82, or accumulate only on a washout below $62 — do not bridge the middle.